Peking Union Medical College Hospital: Carcinoma, Ovarian Epithelial trials

The registry lists 10 Carcinoma, Ovarian Epithelial studies with Peking Union Medical College Hospital as lead sponsor. 4 are open to participants now and 0 have results posted.

Phase 2 4No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Real-World Patient-Reported Outcomes Study in Patients With Long-Term Use of NiraparibRecruitingNCT06037213
• The Effectiveness of Liquid Biopsy in Differential Diagnosis and Early Screening of Epithelial Ovarian CancerNot yet recruitingNCT05931055
• New Serum Biomarkers for Monitoring Early Diagnosis of Ovarian Cancer RecurrenceRecruitingNCT05410028
• Evaluation of Prognostic Monitoring for Women Who Have Completed Standard Treatment for Ovarian CancerRecruitingNCT05410015
• The Efficacy of WeChat-based Multidisciplinary Full-course Nutritional Management ProgramCompletedNCT06379191Not applicable
• A Phase II Trial to Explore Niraparib and Anlotinib Maintenance Retreatment in Platinum-Sensitive Recurrent Ovarian Cancer Patients Previously Treated With PARPiStatus unknownNCT05385068Phase 2
• 68Ga-FAPI-04 and 18F-FDG PET/CT in Patients With Epithelial Ovarian Cancer: Compared With Histological FindingsStatus unknownNCT04504110Phase 2
• Efficacy and Safety of Niraparib Combined With Oral Etoposide in Platinum Resistant/Refractory Recurrent Ovarian CancerStatus unknownNCT04217798Phase 2
• Camrelizumab /Apatinib for Recurrent Platinum-resistant Ovarian CancerStatus unknownNCT04068974Phase 2
• Inherited Susceptible Genes Among Epithelial Ovarian CancerStatus unknownNCT03015376